The effects of prenatal cocaine exposure on reversal learning using a simple visual discrimination task in rhesus monkeys

Neurotoxicology and Teratology

Volumn 25, Issue 4, 2003, Pages 437-446

  Chelonis, John J ^a,b   Gillam, Michael P ^b   Paule, Merle G ^b  

^a UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Adult; Discrimination; Monkeys; Prenatal cocaine; Reversal

Indexed keywords

COCAINE;

ANIMAL EXPERIMENT; ARTICLE; BREEDING; COLOR; COLOR DISCRIMINATION; CONCENTRATION RESPONSE; CONTINGENCY TABLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; LEARNING; LEARNING DISORDER; LEARNING TEST; MENTAL TASK; NEUROTOXICITY; NONHUMAN; PRENATAL DRUG EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; REINFORCEMENT; RHESUS MONKEY; SPATIAL DISCRIMINATION; TASK PERFORMANCE; VISUAL ADAPTATION; VISUAL DISCRIMINATION;

ANIMALIA; MACACA MULATTA;

EID: 0038797806     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0892-0362(03)00017-5     Document Type: Article

References (81)

1. Abelson H.K., Miller J.P. A decade of trends in cocaine use in the household population. Natl. Inst. Drug Abuse Res. Monogr. Ser. 61(1):1985;35-49.
2. Apgar V.A. Proposal for a new method of evaluation of the newborn infant. Anesth. Analg. 32:1952;260-267.
3. Apgar V.A., James L.S. Further observations on the newborn scoring system. J. Am. Med. Assoc. 181:1962;419-428.
4. Bandstra E.S., Burkett G. Maternal-fetal and neonatal effects of in-utero cocaine exposure. Semin. Perinatol. 15:1991;288-301.
5. Barnard K., Eyres S., Lobo M., Snyder C. An ecological paradigm form assessment and intervention. Brazelton T.B., Lester B.M. New Approaches to Developmental Screening of Infants. 1983;199-218 Elsevier, New York.
6. Bayley N. Bayley Scales of Infant Development. 1969;Psychological Corporation, New York.
7. Bendersky M., Lewis M. Prenatal cocaine exposure and impulse control at two years. Harvey J.A., Kosofsky B.E. Cocaine: Effects on the Developing Brain. Ann. N.Y. Acad. Sci. 846:1998;365-367.
8. Benowitz N.L. Clinical pharmacology and toxicology of cocaine. Pharmacol. Toxicol. 72:1993;3-12.
9. Chai L., Choi W.S., Ronnekleiv O.K. Maternal cocaine treatment alters dynorphin and enkephalin mRNA expression in brains of fetal rhesus macaques. J. Neurosci. 17(3):1997;1112-1121.
10. Chandler L.S., Andrews M.S., Swanson M.W. Movement Assessment of Infants. 1980;Infant Movement Research, Rolling Bay, WA.
11. Chasnoff I.J. Drug use and women: Establishing a standard of care. Ann. N.Y. Acad. Sci. 562:1989;208-210.
12. Chasnoff I.J., Anson A., Hatcher R., Stenson H., Iaukea K., Randolph L.A. Prenatal exposure to cocaine and other drugs: Outcome at four to six years. Harvey J.A., Kosofsky B.E. Cocaine: Effects on the Developing Brain. Ann. N.Y. Acad. Sci. 846:1998;314-328.
13. Chasnoff I.J., Burns W.J., Schnoll S.H., Burns K.A. Cocaine use in pregnancy. N. Engl. J. Med. 313(11):1985;666-669.
14. Chasnoff I.J., Griffith D.R. Cocaine use in pregnancy: Perinatal morbidity and mortality. Neurotoxicol. Teratol. 9:1989;291-293.
15. Chasnoff I.J., Griffith D.R., Freier C., Murray J. Cocaine/polydrug use in pregnancy: Two year follow-up. Pediatrics. 89:1992;284-289.
16. Chiriboga C.A. Neurological correlates of fetal cocaine exposure. Harvey J.A., Kosofsky B.E. Cocaine: Effects on the Developing Brain. Ann. N.Y. Acad. Sci. 846:1998;109-125.
17. Choi W.S., Ronnekleiv O.K. Effects of in utero cocaine exposure on the expression of mRNAs encoding the dopamine transporter and the D1, D2 and D5 dopamine receptor subtypes in fetal rhesus monkey. Brain Res. Dev. Brain Res. 96(1-2):1996;249-260.
18. Cohen H.R., Green J.R., Crombleholme W.R. Peripartum cocaine use: Estimating risk of adverse pregnancy outcome. Int. J. Gynecol. Obstet. 35:1991;51-54.
19. Coles C.D., Platzman K.A., Smith I., James M.E., Falek A. Effects of cocaine and alcohol use in pregnancy on neonatal growth and neurobehavioral status. Neurotoxicol. Teratol. 14:1992;22-33.
20. Day N.L., Cottreau C.M., Richardson G.A. The epidemiology of alcohol, marijuana and cocaine use among women of childbearing age and pregnant women. Clin. Obstet. Gynecol. 36:1993;232-245.
21. Day N.L., Robles N. Methodological issues in the measurement of substance abuse. Ann. N.Y. Acad. Sci. 562:1989;8-13.
22. Public Health Rep. 106:1991;59-68.
23. Eyler F.D., Behnke M., Conlon M., Woods N.S., Frentzen B. Prenatal cocaine use: A comparison of neonates matched on maternal risk factors. Neurotoxicol. Teratol. 16:1994;81-87.
24. Finnegan L.P. Neonatal abstinence syndrome: Assessment and pharmacotherapy. Rubiltelli F.F., Cranati B. Neonatal Therapy: An Update. 1986;122-126 Elsevier, New York.
25. Frank D.A., Augustyn M., Zuckerman B.S. Neonatal neurobehavioral and neuroanatomic correlates of prenatal cocaine exposure: Problems of dose and confounding. Harvey J.A., Kosofsky B.E. Cocaine: Effects on the Developing Brain. Ann. N.Y. Acad. Sci. 846:1998;40-50.
26. Frankenburg W.K., Dodd J.B., Fandal A. The Revised Denver Developmental Screening Test Manual. 1970;University of Colorado Press, Denver, CO.
27. Freidman E., Wang H. Prenatal cocaine exposure alters signal transduction in the brain D1 dopamine receptor system. Harvey J.A., Kosofsky B.E. Cocaine: Effects on the Developing Brain. Ann. N.Y. Acad. Sci. 846:1998;238-247.
28. Gabriel M., Taylor C. Prenatal exposure to cocaine impairs neuronal coding of attention and discriminative learning. Harvey J.A., Kosofsky B.E. Cocaine: Effects on the Developing Brain. Ann. N.Y. Acad. Sci. 846:1998;194-212.
29. Garavan H., Morgan R.E., Mactutus C.F., Levitsky D.A., Booze R.M., Strupp B.J. Prenatal cocaine exposure impairs selective attention: Evidence from serial reversal and extradimensional shift tasks. Behav. Neurosci. 114(4):2000;725-738.
30. Gay R. Clinical management of acute and chronic cocaine poisoning. Ann. Emerg. Med. 11:1982;562-571.
31. Graham K., Dimitrakoudis D., Pelligrini E., Koren G. Pregnancy outcome following first trimester exposure to cocaine in social users in Toronto. Vet. Hum. Toxicol. 31:1989;143-148.
32. Hill R.M., Tennyson L.M. Maternal drug therapy: Effect on fetal and neonatal growth and neurobehavior. Neurotoxicology. 7:1986;121-140.
33. Hilson J.A., Strupp B.J. Analyses of response patterns clarify lead effects in olfactory reversal and extradimensional shift tasks: Assessment of inhibitory control, associative ability, and memory. Behav. Neurosci. 111:1997;532-542.
34. Hume R.F., O'Donnell K.J., Stanger C.L., Killam A.P., Gingras J.L. In utero cocaine exposure: Observations of fetal behavioral state may predict neonatal outcome. Am. J. Obstet. Gynecol. 161:1989;685-690.
35. Kain Z.N., Rimar S., Barash P.G. Cocaine abuse in the parturient and effects on the fetus and neonate. Anesth. Analg. 77:1993;835-845.
36. Lewis M., Bendersky M. Lewis M., Bendersky M. Mothers, Babies and Cocaine: The Role of Toxins in Development. 1995;Lawrence Erlbaum, Mahwah, NJ, USA. 397 pp.
37. Li L., Shao J. Restricted lesions to ventral prefrontal subareas block reversal learning but not visual discrimination learning in rats. Physiol. Behav. 65:1998;371-379.
38. Lidow M.S. Nonhuman primate model of the effect of prenatal cocaine exposure on cerebral cortical development. Ann. N.Y. Acad. Sci. 846:1998;182-193.
39. Lidow M.S., Bozian D., Song M.Z. Cocaine affects cerebral neocortical cytoarchitecture in primates only if administered during neocortical neurogenesis. Brain Res. 128(1):2001;45-52.
40. Lidow M.S., Song Z.M. Primates exposed to cocaine in utero display reduced density and number of cerebral cortical neurons. J. Comp. Neurol. 453(3):2001;263-275.
41. Lidow M.S., Song Z.M. Effect of cocaine on cell proliferation in the cerebral wall of monkey fetuses. Cereb. Cortex. 11(6):2001;545-551.
42. Lindenberg C.S., Alexander E.M., Gendrop S.C., Nencioli M., Williams D.G. A review of the literature on cocaine abuse in pregnancy. Nurs. Res. 40:1991;69-75.
43. Loper K.A. Clinical toxicology of cocaine. Med. Toxicol. Adverse Drug Expo. 4:1989;174-185.
44. Mactutus C.F. Prenatal intravenous cocaine adversely affects attentional processing in preweanling rats. Neurotoxicol. Teratol. 21(5):1999;539-550.
45. Mayes L.C., Grillon C., Granger R., Schottenfeld R. Regulation of arousal and attention in preschool children exposed to cocaine prenatally. Harvey J.A., Kosofsky B.E. Cocaine: Effects on the Developing Brain. Ann. N.Y. Acad. Sci. 846:1998;126-143.
46. Means L.W., Hosten R.D. Individual aged rats are impaired on repeated reversal due to loss of different behavioral patterns. Physiol. Behav. 52:1992;959-963.
47. J.P. Miller, National survey on drug abuse, Department of Health and Human Services, Publication No. (ADM) (1983) 83-1263.
48. Morris P., Binienda Z., Gillam M.P., Harkey M.R., Zhou C., Henderson G.L., Paule M.G. The effect of chronic cocaine exposure during pregnancy on maternal and infant outcomes in the rhesus monkey. Neurotoxicol. Teratol. 18(2):1996;147-154.
49. Morris P., Binienda Z., Gillam M.P., Klein J., McMartin K., Koren G., Duhart H.M., Slikker W. Jr., Paule M.G. The effect of chronic cocaine exposure throughout pregnancy on maternal and infant outcomes in the rhesus monkey. Neurotoxicol. Teratol. 19(1):1997;47-57.
50. Morris P., Gillam M., Allen R., Lensing S., Paule M. Operant behavioral responses to pharmacological challenges in rhesus monkey offspring exposed to cocaine. Neurotoxicology. 21(1-2):2000;261.
51. Morris P., Gillam M.P., Allen R.R., Paule M.G. Acute effects of cocaine on operant behavior in rhesus monkey offspring exposed to cocaine in-utero. FASEB J. 9:1994;A631.
52. Morris P., Gillam M.P., Allen R.R., Paule M.G. The effects of chronic cocaine exposure during pregnancy on the acquisition of operant behaviors by rhesus monkey offspring. Neurotoxicol. Teratol. 18(2):1996;155-166.
53. Morris P., Gillam M., Lensing S., Allen R.R., Schulze G.E., Paule M.G. Age-dependent effects of amphetamine on several complex behaviors in rhesus monkeys. Soc. Neurosci. Abstr. 22(1):1996;705.
54. Morris P., Gillam M.P., Paule M.G. Acute effects of quinpirole on operant behavior in rhesus monkey offspring exposed to cocaine in-utero. Neurotoxicol. Teratol. 22:2000;455-456.
55. Morris P., Gillam M.P., Paule M.G. Acute effects of spiperone on operant behavior in rhesus monkey offspring exposed to cocaine in utero. Neurotoxicol. Teratol. 23:2001;288.
56. Nair B.S., Watson R.R. Cocaine and the pregnant woman. J. Reprod. Med. 36:1991;862-867.
57. Neuspiel D.R., Hamel S.C., Hochberg E., Greene J., Campbell D. Maternal cocaine use and infant behavior. Neurotoxicol. Teratol. 13:1991;229-233.
58. National Institute on Drug Abuse (NIDA), National Pregnancy and Health Survey, Drug Abuse among Women Delivering Live Births: 1992, National Institutes of Health Publication No. 96-3819, 1996.
59. Oro A.S., Dixon S.D. Perinatal cocaine and methamphetamine exposure: Maternal and neonatal correlates. J. Pediatr. 111:1987;571-578.
60. Paule M.G., Chelonis J.J., Buffalo E.A., Blake D.J., Casey P.H. Operant test battery performance in children: Correlation with IQ. Neurotoxicol. Teratol. 21(3):1999;223-230.
61. Paule M.G., Forrester T.M., Maher M.A., Cranmer J.M., Allen R.R. Monkey versus human performance in the NCTR operant test battery. Neurotoxicol. Teratol. 12(5):1990;503-507.
62. Paule M.G., Gillam M.P., Allen R.R., Morris P. Age-dependent effects of cocaine on several complex behaviors in rhesus monkeys. Soc. Neurosci. Abstr. 21(1):1995;707.
63. Paule M.G., Gillam M.P., Morris P. The effects of cocaine on nonhuman primate brain function are age-dependent. Ann. N.Y. Acad. Sci. 844:1998;178-182.
64. Prakash A., Das G. Cocaine and the nervous system. Int. J. Pharmacol. Ther. Toxicol. 31:1993;575-581.
65. Richardson G.A. Prenatal cocaine exposure: A longitudinal study of development. Harvey J.A., Kosofsky B.E. Cocaine: Effects on the Developing Brain. Ann. N.Y. Acad. Sci. 846:1998;144-152.
66. Richardson G.A., Day N.L. Maternal and neonatal effects of moderate cocaine use during pregnancy. Neurotoxicol. Teratol. 13:1991;455-460.
67. Romano A.G., Harvey J.A. Prenatal exposure to cocaine disrupts discrimination learning in adult rabbits. Pharmacol. Biochem. Behav. 53(3):1996;617-621.
68. Romano A.G., Harvey J.A. Elicitation and modification of the rabbit's nictitating membrane reflex following prenatal exposure to cocaine. Pharmacol. Biochem. Behav. 53(4):1996;857-862.
69. Romano A.G., Harvey J.A. Prenatal cocaine exposure: Long-term deficits in learning and motor performance. Harvey J.A., Kosofsky B.E. Cocaine: Effects on the Developing Brain. Ann. N.Y. Acad. Sci. 846:1998;89-108.
70. Romano A.G., Kachelries W.J., Simansky K.J., Harvey J.A. Intrauterine exposure to cocaine produces a modality-specific acceleration of classical conditioning in adult rabbits. Pharmacol. Biochem. Behav. 52(2):1995;415-420.
71. Ronnekleiv O.K., Fang Y., Choi W.S., Chai L. Changes in the midbrain-rostral forebrain dopamine circuitry in the cocaine-exposed primate fetal brain. Harvey J.A., Kosofsky B.E. Cocaine: Effects on the Developing Brain. Ann. N.Y. Acad. Sci. 846:1998;165-181.
72. Ronnekleiv O.K., Naylor B.R. Chronic cocaine exposure in the fetal rhesus monkey: Consequences for early development of dopamine neurons. J. Neurosci. 15(11):1995;7330-7343.
73. Ryan L., Ehrlich S., Finnegan L. Cocaine abuse in pregnancy: Effects on the fetus and newborn. Neurotoxicol. Teratol. 9:1987;295-299.
74. Schmajuk N.A., Blair H.T. Time, space, and the hippocampus. Spear N.E., Spear L.P., Woodruff M.L. Neurobehavioral Plasticity. 1995;33-56 Erlbaum, Hillsdale, NJ.
75. Schneider J.N., Chasnoff I.J. Motor assessment of cocaine/polydrug exposed infants at 4 months of age. Neurotoxicol. Teratol. 14:1992;97-101.
76. Schulze G.E., McMillan D.E., Bailey J.R., Scallet A., Ali S.F., Slikker W. Jr., Paule M.G. Acute effects of delta-9-tetrahydrocannabinol in rhesus monkeys as measured by performance in a battery of complex operant tests. J. Exp. Pharmacol. Ther. 245:1988;178-186.
77. Simansky K.J., Baker G., Kachelries W.J., Hood H., Romano A.G., Harvey J.A. Prenatal exposure to cocaine reduces dopaminergic D1-mediated motor function but spares the enhancement of learning by amphetamine in rabbits. Ann. N.Y. Acad. Sci. 846:1998;375-378.
78. Slutsker L. Risks associated with cocaine use during pregnancy. Obstet. Gynecol. 79:1992;778-789.
79. Spear L.P. Alterations in cognitive function following prenatal cocaine exposure: Studies in an animal model. Lewis M., Bendersky M. Mothers, Babies, and Cocaine: The Role of Toxins in Development. 1995;207-227 Erlbaum, Hillsdale, NJ.
80. Spear L.P., Campbell J., Snyder K., Silveri M., Katovic N. Animal behavior models: Increased sensitivity to stressors and other environmental experiences after prenatal cocaine exposure. Harvey J.A., Kosofsky B.E. Cocaine: Effects on the Developing Brain. Ann. N.Y. Acad. Sci. 846:1998;76-88.
81. Vorhees C.V. A review of developmental exposure models for CNS stimulants: Cocaine. Lewis M., Bendersky M. Mothers, Babies, and Cocaine: The Role of Toxins in Development. 1995;71-94 Erlbaum, Hillsdale, NJ.